Cargando…

P2Y2R Signaling Is Involved in the Onset of Glomerulonephritis

Endogenously released adenosine-5’-triphosphate (ATP) is a key regulator of physiological function and inflammatory responses in the kidney. Genetic or pharmacological inhibition of purinergic receptors has been linked to attenuation of inflammatory disorders and hence constitutes promising new aven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rennert, Laura, Zschiedrich, Stefan, Sandner, Lukas, Hartleben, Björn, Cicko, Sanja, Ayata, Cemil Korcan, Meyer, Charlotte, Zech, Andreas, Zeiser, Robert, Huber, Tobias B., Idzko, Marco, Grahammer, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054981/ https://www.ncbi.nlm.nih.gov/pubmed/30061884 http://dx.doi.org/10.3389/fimmu.2018.01589

Ejemplares similares

P2rx4 deficiency in mice alleviates allergen-induced airway inflammation
por: Zech, Andreas, et al.
Publicado: (2016)

Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI)
por: Cicko, Sanja, et al.
Publicado: (2018)

Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
por: Cicko, Sanja, et al.
Publicado: (2015)

CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells
por: Kuhny, Marcel, et al.
Publicado: (2014)

P2Y(6) Receptor Activation Promotes Inflammation and Tissue Remodeling in Pulmonary Fibrosis
por: Müller, Tobias, et al.
Publicado: (2017)

The purinergic receptor subtype P2Y(2) mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease
por: Müller, Tobias, et al.
Publicado: (2017)

Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33
por: Calvén, Jenny, et al.
Publicado: (2015)

Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP
por: Scherr, Benedikt F., et al.
Publicado: (2023)

AMP Affects Intracellular Ca(2+) Signaling, Migration, Cytokine Secretion and T Cell Priming Capacity of Dendritic Cells
por: Panther, Elisabeth, et al.
Publicado: (2012)

Microtubule Associated Protein 1b (MAP1B) Is a Marker of the Microtubular Cytoskeleton in Podocytes but Is Not Essential for the Function of the Kidney Filtration Barrier in Mice
por: Gödel, Markus, et al.
Publicado: (2015)

Parietal epithelial cell dysfunction in crescentic glomerulonephritis
por: Wong, Milagros N., et al.
Publicado: (2021)

Role of purinergic signaling in experimental pneumococcal meningitis
por: Zierhut, Marco, et al.
Publicado: (2017)

5-Hydroxytryptamine Modulates Migration, Cytokine and Chemokine Release and T-Cell Priming Capacity of Dendritic Cells In Vitro and In Vivo
por: Müller, Tobias, et al.
Publicado: (2009)

Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation
por: Schneider, Sven, et al.
Publicado: (2022)

Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis
por: Henique, Carole, et al.
Publicado: (2017)

The Copper/Zinc Ratio Correlates With Markers of Disease Activity in Patients With Inflammatory Bowel Disease
por: Schneider, Tobias, et al.
Publicado: (2020)

Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report
por: Czogalla, Jan, et al.
Publicado: (2021)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Cell Loss and Autophagy in the Extra-Adrenal Chromaffin Organ of Zuckerkandl are Regulated by Glucocorticoid Signalling
por: Schober, Andreas, et al.
Publicado: (2013)

Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity
por: Weber, Felix C., et al.
Publicado: (2010)

Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease
por: Melhem, Hassan, et al.
Publicado: (2019)

Phospholipase A2 Receptor-Positive Idiopathic Membranous Glomerulonephritis with Onset at 95 Years: Case Report
por: Kubota, Keiichi, et al.
Publicado: (2016)

Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased
por: Diebold, Matthias, et al.
Publicado: (2022)

Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017)

MMP2 and MMP9 associate with crescentic glomerulonephritis
por: Phillips, Tessa M., et al.
Publicado: (2017)

Membranoproliferative glomerulonephritis
por: Alchi, Bassam, et al.
Publicado: (2009)

Cryoglobulinemic Glomerulonephritis as a Presentation of Atypical Post-Infectious Glomerulonephritis
por: Boumitri, Christine, et al.
Publicado: (2016)

Sjögren Syndrome-Related Membranous Glomerulonephritis Progressing to Membranoproliferative Glomerulonephritis
por: Yabuuchi, Junko, et al.
Publicado: (2016)

Fibrillary Glomerulonephritis with Crescentic and Necrotizing Glomerulonephritis and Concurrent Thrombotic Microangiopathy
por: Tsui, Calvin, et al.
Publicado: (2018)

Fibrillary Glomerulonephritis: A Great Mimicker of Rapidly Progressive Glomerulonephritis
por: Raikar, Manisha, et al.
Publicado: (2022)

Glomerulonephritis-induced changes in kidney gene expression in rats
por: Pavkovic, Mira, et al.
Publicado: (2015)

STUDIES IN GLOMERULONEPHRITIS : III. AN ATTEMPT TO PRODUCE GLOMERULONEPHRITIS BY REPEATED INJECTIONS OF BACTERIA.
por: Faber, Harold Kniest, et al.
Publicado: (1917)

A high-throughput drug discovery pipeline to optimize kidney normothermic machine perfusion
por: Hofmann, Smilla, et al.
Publicado: (2022)

Immunosuppressant Agents in the Treatment of Glomerulonephritis: Part 2. Cytotoxic Drugs
por: Cameron, J. S.
Publicado: (1971)

Benzylthiouracil-Induced Glomerulonephritis
por: Trimeche Ajmi, Sihem, et al.
Publicado: (2009)

Hypertension in Chronic Glomerulonephritis
por: Ihm, Chun-Gyoo
Publicado: (2015)

Fibrillary Glomerulonephritis: An Update
por: Rosenstock, Jordan L., et al.
Publicado: (2019)

Immunological Mechanisms in Glomerulonephritis
por: Hardwicke, J.
Publicado: (1971)

Treatment of Primary Glomerulonephritis
por: Oliveira, David B G
Publicado: (1997)

Crescentic glomerulonephritis in children
por: Mayer, Ulrike, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sv33nggj6gj21nqmk4fjpd2qom